İ. TURAN Et Al. , "Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy," LIVER TRANSPLANTATION , vol.21, no.8, pp.1066-1075, 2015
TURAN, İ. Et Al. 2015. Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy. LIVER TRANSPLANTATION , vol.21, no.8 , 1066-1075.
TURAN, İ., YAPALI, S., Bademkiran, F., KÖSE, T., DUMAN, S., Sozbilen, M., ... Gunsar, F.(2015). Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy. LIVER TRANSPLANTATION , vol.21, no.8, 1066-1075.
TURAN, İLKER Et Al. "Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy," LIVER TRANSPLANTATION , vol.21, no.8, 1066-1075, 2015
TURAN, İLKER Et Al. "Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy." LIVER TRANSPLANTATION , vol.21, no.8, pp.1066-1075, 2015
TURAN, İ. Et Al. (2015) . "Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy." LIVER TRANSPLANTATION , vol.21, no.8, pp.1066-1075.
@article{article, author={İLKER TURAN Et Al. }, title={Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy}, journal={LIVER TRANSPLANTATION}, year=2015, pages={1066-1075} }